Efficacy Regarding Renal Function of Everolimus in Combination With Specific Standard Immunosuppressive Regimen Lung Transplant Recipients
Clinical trial NCT01404325 · COMPLETED
Trial details
- NCT number
- NCT01404325
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2017-01-05
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.